Last $5.37 USD
Change Today +0.03 / 0.56%
Volume 729.4K
XNPT On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - xenoport inc (XNPT)

Name (Connections)Board RelationshipsTitleKey Developments
John Freund M.D. 112 RelationshipsLead Director, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee 
Jeryl Hilleman M.B.A 8 RelationshipsIndependent Director and Chairman of Audit Committee 
Catherine Friedman 31 RelationshipsDirector, Member of Nominating & Corporate Governance Committee and Member of Audit Committee 

Compensation Committee* - xenoport inc (XNPT)

Name (Connections)Board RelationshipsTitle
Paul Berns 47 RelationshipsIndependent Director and Chairman of Compensation Committee
Dennis Fenton Ph.D. 233 RelationshipsDirector and Member of Compensation Committee
Wendell Wierenga Ph.D. 125 RelationshipsIndependent Director and Member of Compensation Committee
XNPT Compensation vs. Industry
500.0K
420.4K
Chief Executive Officer
369.2K
271.5K
Chief Financial Officer
426.4K
368.4K
Chief Operating Officer
Share price activity for XENOPORT INC (XNPT)
52 Week Price Performance
XNPT
Industry Average

Nominating Committee* - xenoport inc (XNPT)

Name (Connections)Board RelationshipsTitleKey Developments
John Freund M.D. 112 RelationshipsLead Director, Chairman of Nominating & Corporate Governance Committee and Member of Audit CommitteeXenoport Appoints Richard Kim as Senior Vice President, Clinical Development and Medical Affairs, and Chief Medical Officer
02/8/14
Catherine Friedman 31 RelationshipsDirector, Member of Nominating & Corporate Governance Committee and Member of Audit CommitteeXenoport, Inc. Appoints Richard Kim as Senior Vice President, Clinical Development and Medical Affairs and Chief Medical Officer
01/29/14
Ernest Mario Ph.D. 286 RelationshipsDirector and Member of Nominating & Corporate Governance CommitteeXenoport, Inc. Appoints Ernest Mario to its Board of Directors
06/18/12

Corporate Governance Committee* - xenoport inc (XNPT)

Name (Connections)Board RelationshipsTitle
John Freund M.D. 112 RelationshipsIndependent Director and Chairman of Compensation Committee
Catherine Friedman 31 RelationshipsDirector and Member of Compensation Committee
Ernest Mario Ph.D. 286 RelationshipsIndependent Director and Member of Compensation Committee
XNPT and Competitor
Insiders vs. External
Board
22%
78%
Xenoport, Inc.
8%
92%
Flamel Technologies SA
17%
83%
Access Pharmaceuticals Inc.
14%
86%
DepoMed Inc.
38%
62%
BioDelivery Sciences International, Inc.
13%
87%
Biocon Limited
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XNPT:US $5.37 USD +0.03

XNPT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Access Pharmaceuticals Inc $0.27 USD +0.005
Biocon Ltd 507.90 INR +7.85
BioDelivery Sciences International Inc $17.02 USD -0.33
Depomed Inc $14.72 USD -0.24
Flamel Technologies SA $14.77 USD +0.305
View Industry Companies
 

Industry Analysis

XNPT

Industry Average

Valuation XNPT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 23.6x
Price/Book 3.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 14.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XENOPORT INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.